Actively Recruiting
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Led by Intellia Therapeutics · Updated on 2025-08-26
72
Participants Needed
4
Research Sites
764 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
CONDITIONS
Official Title
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Completed or discontinued from an Intellia-sponsored clinical study where a full or partial dose of NTLA-2001 was received
- Provided informed consent for this long-term follow-up study
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Clinical Trial Site
Paris, France
Actively Recruiting
2
Clinical Trial Site
Auckland, New Zealand
Actively Recruiting
3
Clinical Trial Site
Umeå, Sweden
Actively Recruiting
4
Clinical Trial Site
London, United Kingdom
Actively Recruiting
Research Team
T
Trial Manager at Intellia
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here